Overview

Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer

Status:
Not yet recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
Comparison of docetaxel and Nab-paclitaxel in neoadjuvant chemotherapy for breast cancer
Phase:
Phase 1
Details
Lead Sponsor:
Xuli Meng
Treatments:
Docetaxel
Paclitaxel